Estarylla Kit
Product Images NDC 70700-119

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Estarylla (NDC 70700-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart

A chart comparing birth control methods ordered by effectiveness, showing fewer pregnancies per 100 women per year at the top and more pregnancies at the bottom. Methods with fewer pregnancies include implants, injections, intrauterine devices, and sterilization. Birth control pills, skin patch, vaginal ring with hormones, condoms, and diaphragm are in the middle range. Less effective or no birth control methods like no sex during fertile days, spermicide, withdrawal, and no birth control are listed near the bottom indicating higher pregnancy rates.*

FDA Label Image

Estarylla-blister (Estarylla Blister)

An instructional diagram for Estarylla, a norgestimate and ethinyl estradiol tablet kit by Xiromed, LLC. It shows four weekly rows of circles representing daily tablet intake: three weeks of white circles followed by one week of shaded circles, with each circle labeled for a day from Sunday to Saturday. Arrows indicate the sequence for taking tablets starting from Sunday of Week 1 to Saturday of Week 4.*

FDA Label Image

Estarylla-carton (Estarylla Carton)

Flat layout of the Estarylla Kit packaging label, a prescription drug by Xiromed, LLC. The product contains Norgestimate and Ethinyl Estradiol tablets USP, with strengths of 0.25 mg and 0.035 mg respectively. The label indicates it includes 3 units of 3x28 tablet blister cards. The packaging features teal and white colors with text detailing product information, NDC 70700-119, and manufacturer details including Laboratorios León Farma S.A., Spain.*

FDA Label Image

Figure 2

A forest plot graph showing effect estimates (OR/RR) with confidence intervals from various studies on women's health. Studies range from 2002 to 2017, including the NICHD Women's Contraceptive Study, French E3N cohort, Shanghai Women's Health Study, and others. The x-axis represents effect estimates from -1.5 to 2, with data points near or above 1.0, indicating varied risk measurements.*

FDA Label Image

Structure Ee

Chemical structure of ethinyl estradiol, the active ingredient in Estarylla. The diagram shows the molecular configuration with labeled functional groups and bonds characteristic of ethinyl estradiol.*

FDA Label Image

Structure Norgestimate

Chemical structure of Norgestimate, the active ingredient in Estarylla. The diagram depicts the molecular framework characteristic of this synthetic progestin used in combination oral contraceptives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.